Lymphoplasmacytic lymphoma
MONDO:0000432A clonal neoplasm of small B-lymphocytes, lymphoplasmacytoid cells, and plasma cells involving the bone marrow, lymph nodes, and the spleen. The majority of patients have a serum IgM paraprotein.
Also known as: Immunocytoma, lymphoplasmacytic type, lymphoma, lymphoplasmacytic, malignant, lymphoma, plasmacytic, lymphoplasmacytic lymphoma, lymphoplasmacytic lymphoma (Waldenstrom macroglobulinemia), lymphoplasmacytoid lymphoma
2062 clinical trials for this condition and its sub-types, 44 tagged with Lymphoplasmacytic lymphoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Lymphoplasmacytic lymphoma
-
Waldenstrom macroglobulinemia 136 trials
2 sub-types
- Macroglobulinemia, Waldenstrom, 1 2 trials
- Macroglobulinemia, Waldenstrom, 2 0 trials
-
Smart blood pressure cuffs could protect cancer patients from heart risks
Disease control Not yet recruitingThis pilot study tests whether a connected blood pressure monitor, supervised daily by a healthcare assistant, helps patients with blood cancers like CLL or lymphoma stick to home monitoring. The goal is to catch and manage high blood pressure early, a common side effect of BTK i…
Sponsor: Centre Hospitalier de la côte Basque • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New cocktail aims to tame Slow-Growing blood cancers
Disease control Not yet recruitingThis Phase II trial will test a combination of pomalidomide, an anti-CD20 antibody, and prednisone as a first treatment for people with indolent (slow-growing) B-cell lymphomas. About 30 adults who have not had prior therapy will receive six cycles of the combo, followed by two y…
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New dual-target CAR-T therapy takes on hard-to-treat blood cancers
Disease control Not yet recruitingThis early-phase study tests a new treatment called CAR19-BCMA CAR-T for people with certain blood cancers (plasma cell neoplasms or lymphomas/leukemias) that have returned or not responded to at least three prior treatments. The therapy uses a patient's own immune cells, modifie…
Early phase 1 • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New study investigates brain fog after CAR-T and bispecific antibody therapies
Knowledge-focused Not yet recruitingThis study will follow 225 blood cancer patients receiving CAR-T therapy, bispecific antibodies, or high-dose chemotherapy with stem cell transplant. Researchers will test memory, attention, and thinking skills before treatment and up to 3 years after. The goal is to understand h…
Sponsor: Aarhus University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC